Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rodeghiero

Showing results (241-250 of 266) with videos related to

Pageof 27
Sort By:
Thrombosis and Haemostasis|October 22, 1990
Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factorP d'Alessio, J J Zwaginga, H C de Boer, et al.
Journal of Thrombosis and Haemostasis : JTH|June 20, 2014
Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factorsM Ruggeri, A Tosetto, F Palandri, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2005
The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter studyF Rodeghiero, G Castaman, A Tosetto, et al.
Haematologica|September 1, 1996
Therapeutic impact of adult-type acute lymphoblastic leukemia regimens in B-cell/L3 acute leukemia and advanced-stage Burkitt's lymphomaT Lerede, R Bassan, A Rossi, et al.
Journal of Thrombosis and Haemostasis : JTH|September 27, 2006
Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter studyG Castaman, F Rodeghiero, A Tosetto, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 2011
A comparison between two semi-quantitative bleeding scales for the diagnosis and assessment of bleeding severity in type 1 von Willebrand diseaseA Tosetto, F Rodeghiero, G Castaman, et al.
Thrombosis Research|July 24, 2010
Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWDG Castaman, A Tosetto, A Cappelletti, et al.
Leukemia|September 20, 2011
Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteriaG Finazzi, A Carobbio, J Thiele, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 25, 2018
Fifth Åland Island conference on von Willebrand diseaseE Berntorp, A Ågren, L Aledort, et al.
Blood Cancer Journal|December 1, 2015
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemiaT Barbui, A M Vannucchi, V Buxhofer-Ausch, et al.
Pageof 27

Showing results (241-250 of 266) with videos related to

Sort By:
Pageof 27
Thrombosis and Haemostasis|October 22, 1990
Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factorP d'Alessio, J J Zwaginga, H C de Boer, et al.
Journal of Thrombosis and Haemostasis : JTH|June 20, 2014
Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factorsM Ruggeri, A Tosetto, F Palandri, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2005
The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter studyF Rodeghiero, G Castaman, A Tosetto, et al.
Haematologica|September 1, 1996
Therapeutic impact of adult-type acute lymphoblastic leukemia regimens in B-cell/L3 acute leukemia and advanced-stage Burkitt's lymphomaT Lerede, R Bassan, A Rossi, et al.
Journal of Thrombosis and Haemostasis : JTH|September 27, 2006
Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter studyG Castaman, F Rodeghiero, A Tosetto, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 2011
A comparison between two semi-quantitative bleeding scales for the diagnosis and assessment of bleeding severity in type 1 von Willebrand diseaseA Tosetto, F Rodeghiero, G Castaman, et al.
Thrombosis Research|July 24, 2010
Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWDG Castaman, A Tosetto, A Cappelletti, et al.
Leukemia|September 20, 2011
Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteriaG Finazzi, A Carobbio, J Thiele, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 25, 2018
Fifth Åland Island conference on von Willebrand diseaseE Berntorp, A Ågren, L Aledort, et al.
Blood Cancer Journal|December 1, 2015
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemiaT Barbui, A M Vannucchi, V Buxhofer-Ausch, et al.
Pageof 27